BioDelivery Sciences International, Inc. is a specialty pharmaceutical company in the United States which specializes in drug delivery technologies that include BEMA drug delivery technology and Bioral cochleate drug delivery technology. The company focuses on delivering innovative and effective solutions for patients with chronic and acute pain conditions. They have developed a range of patented products that are designed to provide unique formulations, enabling better treatment options for patients who are in need of pain relief. The company's mission is to improve the quality of life for patients and make healthcare more accessible and affordable. They are committed to working towards creating value for shareholders and stakeholders, while also maintaining high ethical standards in their operations.